SCHEMBL8264669

SCHEMBL8264669

Cc1cccc(-c2ccc(F)c(O)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.65
HSD17B2 P37059 6/20 0.65
APP P05067 1/20 0.47
ESR2 Q92731 1/20 0.44
RPS6KA3 P51812 1/20 0.44
ALOX5 P09917 1/20 0.44
KDM1A O60341 1/20 0.44
ACHE P22303 2/20 0.43
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
PTPN5 P54829 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PDK2 Q15119 1/20 0.42
HSD17B14 Q9BPX1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8265220 0.85 HSD17B1 (0.65) HSD17B1HSD17B2APPESR2RPS6KA3
SCHEMBL12225756 0.82 ACHE (0.48) HSD17B1HSD17B2RPS6KA3ACHEPTPN5
SCHEMBL21363207 0.82 APP (0.71) HSD17B1HSD17B2APPESR2ALOX5
SCHEMBL15344106 0.80 ACHE (0.46) HSD17B1HSD17B2ESR2ACHEPTPN5
SCHEMBL3625237 0.79 HSD17B1 (0.74) HSD17B1HSD17B2APPESR2ALOX5
SCHEMBL6250509 0.79 RPS6KA3 (0.47) HSD17B1HSD17B2APPRPS6KA3ACHE
Metacresol SCHEMBL10549611 0.77 ACHE (0.65) HSD17B1HSD17B2ACHECA3CA6
SCHEMBL14381080 0.77 AKR1C2 (0.47) ESR2ACHE
SCHEMBL5845469 0.77 HSD17B10 (0.65) HSD17B1HSD17B2APPACHEHDAC8
SCHEMBL12127 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177518-A1 Organic compounds Novartis AG (CH) 2010-04-21 EP disclosed
EP-1833816-B1 SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-11-11 EP disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 WO disclosed